According to the World Health Organization reported that in 2017, the total cost of healthcare per person worldwide was USD 1,064.741. The cost of healthcare per person worldwide increased from USD 864.313 in 2008 to USD 1,110.841 in 2018, with the United States as the top payer at USD 10, 623.85 per capita in 2018. Domestic general government healthcare spending in the United States increased from USD 3515.82 in 2008 to USD 5355.79 in 2018. These are a few of the elements that have contributed to market expansion in recent years.
Frequently Asked Questions
The market is segmented based on Segmentation, By Condition (Epilepsy Drug Resistant/Intractable Epilepsy, Others), Drug (First-Generation, Second-Generation, Third-Generation), Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies), End Users (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers) – Industry Trends and Forecast to 2031
.
The Global Epilepsy Treatment Market size was valued at USD 6.50 USD Million in 2023.
The Global Epilepsy Treatment Market is projected to grow at a CAGR of 6.2% during the forecast period of 2024 to 2031.
The major players operating in the market include Pfizer , Novartis AG, Abbott, Neurelis , GSK plc, Johnson & Johnson Services , Teva Pharmaceutical Industries , Sumitomo Dainippon Pharma Co. Ltd, Bausch Health Companies , Sanofi, Takeda Pharmaceutical Company Limited, UCB S.A., Marinus Pharmaceuticals , Eisai Co. Ltd, H. Lundbeck A/S, Supernus Pharmaceuticals , DAIICHI SANKYO COMPANY LIMITED.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
